BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for KYVERNA THERAPEUTICS, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · $20,000.00 income · posted Apr 19, 2026

Lobbying activity 1

Pharmacy

Outreach regarding cell therapies for autoimmune diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem